FINALLY, that's hugely positive news - my daughter has asthma, so I'll get some from the chemist today to see if it makes a difference.
It's a large market potential for Biome:
- Around 2.7 million Australians (11% of the total population) have asthma, based on self‑reported data from the 2017–18 Australian Bureau of Statistics (ABS) National Health Survey (NHS) (ABS 2018).
In the UK, over 8 million people, or approximately 12% of the population, have been diagnosed with asthma.
Ann: Clinical trial on asthma sufferers validates Biome probiotic, page-2
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $65.97M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.5¢ | $19.67K | 63.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17246 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 2213 | 1 |
View Market Depth
| Last trade - 15.52pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
30.5¢ |
Change
-0.005 ( 1.67 %) |
||||
| Open | High | Low | Volume | ||
| 30.5¢ | 31.0¢ | 30.0¢ | 54461 | ||
| Last updated 15.39pm 10/05/2024 ? | |||||
| BIO (ASX) Chart |